🔗 Visit the ClinicalTrials.gov page for NCT04338438
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. | Lancet Oncol | 2020 | 18.57 |
| 2 | Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. | N Engl J Med | 2007 | 12.62 |
| 3 | Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial. | Lancet Oncol | 2014 | 2.69 |
| 4 | Apatinib for chemotherapy-refractory advanced metastatic gastric cancer: results from a randomized, placebo-controlled, parallel-arm, phase II trial. | J Clin Oncol | 2013 | 2.69 |
| 5 | Apatinib: A novel receptor tyrosine kinase inhibitor for the treatment of gastric cancer. | Cancer Lett | 2016 | 0.84 |
| 6 | The challenge of screening for early gastric cancer in China. | Lancet | 2016 | 0.76 |